• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN
January 31, 2023 02:26 PM EST
FDA+

Pan­dem­ic wait is over: FDA be­gins tran­si­tion to in-per­son meet­ings in March

Zachary Brennan

Senior Editor

It’s been al­most three years since any­one has met with FDA staff in per­son at an FDA of­fice. But that’s all about to change as …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

more like this

  • FDA re­scinds lab-de­vel­oped test rule af­ter court or­der September 18, 2025
  • Replimune's stock sinks on rocky path for­ward for can­cer drug's ac­cel­er­at­ed ap­proval September 18, 2025
  • As the fall vac­ci­na­tion sea­son be­gins, a patch­work ef­fort fills void left by CDC September 17, 2025
TRENDING NOW

Roche to en­ter FGF21 space with $2.4B buy­out of MASH biotech 89bio

Pfiz­er, Arv­inas to sell rights to lead PRO­TAC one month af­ter fil­ing for FDA re­view

Shape Ther­a­peu­tics strikes AAV cap­sid deal with Vec­to­rY worth up to $1.2B

Aca­dia de­lays UK drug launch plans due to high mar­ket en­try bar­ri­er for biotechs

Up­dat­ed: ACIP votes to not rec­om­mend com­bined MM­RV shot for kids un­der 4, spurring ac­cess con­fu­sion

Rare pe­di­atric vouch­er reau­tho­riza­tion again ad­vances out of House com­mit­tee

Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times